| 1YUY | A: | HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE GENOTYPE 2A |
| 1YV2 | A: | HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE GENOTYPE 2A |
| 1YVF | A: | HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE COMPLEX WITH INHIBITOR PHA-00729145 |
| 1YVX | A: | HEPATITIS C VIRUS RNA POLYMERASE GENOTYPE 2A IN COMPLEX WITH NON- NUCLEOSIDE ANALOGUE INHIBITOR |
| 1YVZ | A: | HEPATITIS C VIRUS RNA POLYMERASE GENOTYPE 2A IN COMPLEX WITH NON- NUCLEOSIDE ANALOGUE INHIBITOR |
| 1Z4U | A: | HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE COMPLEX WITH INHIBITOR PHA-00799585 |
| 2AWZ | A:; B: | HEPATITIS C VIRUS NS5B RNA POLYMERASE IN COMPLEX WITH A COVALENT INHIBITOR (5H) |
| 2AX0 | A:; B: | HEPATITIS C VIRUS NS5B RNA POLYMERASE IN COMPLEX WITH A COVALENT INHIBITOR (5X) |
| 2AX1 | A:; B: | HEPATITIS C VIRUS NS5B RNA POLYMERASE IN COMPLEX WITH A COVALENT INHIBITOR (5EE) |
| 2D3U | A:; B: | X-RAY CRYSTAL STRUCTURE OF HEPATITIS C VIRUS RNA DEPENDENT RNA POLYMERASE IN COMPLEX WITH NON-NUCLEOSIDE ANALOGUE INHIBITOR |
| 2D3Z | A:; B: | X-RAY CRYSTAL STRUCTURE OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH NON-NUCLEOSIDE ANALOGUE INHIBITOR |
| 2D41 | A:; B: | X-RAY CRYSTAL STRUCTURE OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR |
| 2DXS | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B RNA POLYMERASE COMPLEXED WITH A TETRACYCLIC INHIBITOR |
| 2GC8 | A:; B: | STRUCTURE OF A PROLINE SULFONAMIDE INHIBITOR BOUND TO HCV NS5B POLYMERASE |
| 2HWH | A:; B: | HCV NS5B ALLOSTERIC INHIBITOR COMPLEX |
| 2HWI | A:; B: | HCV NS5B ALLOSTERIC INHIBITOR COMPLEX |
| 2I1R | A:; B: | NOVEL THIAZOLONES AS HCV NS5B POLYMERASE INHIBITORS: FURTHER DESIGNS, SYNTHESIS, SAR AND X-RAY COMPLEX STRUCTURE |
| 2JC0 | A:; B: | CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB655264 |
| 2JC1 | A:; B: | CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB698223 |
| 2O5D | A:; B: | THIAZOLONE-ACYLSULFONAMIDES AS NOVEL HCV NS5B POLYMERASE ALLOSTERIC INHIBITORS: CONVERGENCE OF STRUCTURE-BASED DRUG DESIGN AND X-RAY CRYSTALLOGRAPHIC STUDY |
| 2XHU | A:; B: | HCV-J4 NS5B POLYMERASE ORTHORHOMBIC CRYSTAL FORM |
| 2XHV | A:; B: | HCV-J4 NS5B POLYMERASE POINT MUTANT ORTHORHOMBIC CRYSTAL FORM |
| 2XHW | A: | HCV-J4 NS5B POLYMERASE TRIGONAL CRYSTAL FORM |
| 2XI2 | A:; B:; C: | HCV-H77 NS5B APO POLYMERASE |
| 2XI3 | A:; B: | HCV-H77 NS5B POLYMERASE COMPLEXED WITH GTP |
| 2XWY | A: | STRUCTURE OF MK-3281, A POTENT NON-NUCLEOSIDE FINGER-LOOP INHIBITOR, IN COMPLEX WITH THE HEPATITIS C VIRUS NS5B POLYMERASE |
| 2XXD | A: | HCV-JFH1 NS5B POLYMERASE STRUCTURE AT 1.9 ANGSTROM |
| 3BR9 | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE WITH A NOVEL PYRIDAZINONE INHIBITOR |
| 3CDE | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE WITH A NOVEL PYRIDAZINONE INHIBITOR |
| 3CWJ | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE WITH A NOVEL PYRIDAZINONE INHIBITOR |
| 3PHE | A:; B:; C:; D: | HCV NS5B WITH A BOUND QUINOLONE INHIBITOR |
| 3VQS | A:; B:; C:; D: | CRYSTAL STRUCTURE OF HCV NS5B RNA POLYMERASE WITH A NOVEL PIPERAZINE INHIBITOR |
| 4ADP | A: | HCV-J6 NS5B POLYMERASE V405I MUTANT |
| 4AEP | A: | HCV-JFH1 NS5B POLYMERASE STRUCTURE AT 1.8 ANGSTROM |
| 4AEX | A:; B: | HCV-JFH1 NS5B POLYMERASE STRUCTURE AT 2.4 ANGSTROM IN A PRIMITIVE ORTHORHOMBIC SPACE GROUP |
)
)